TAT GIDA SANAYİ A.Ş.

Share Issue/Capital Change • Feb 28, 2025

Summary Info	CMB Approval for the Increase in Registered Authorized Capital and Extension of the Validity Period
Update Notification Flag	Yes
Correction Notification Flag	No
Postponed Notification Flag	No

Board Decision Date	20.02.2025
Related Authorized Capital Process	Increase Of Authorized Capital
Current Authorized Capital (TL)	250.000.000
New Authorized Capital (TL)	2.000.000.000
Due Date For The Authorized Capital (New)	31.12.2029
Number Of Articles Of Association Item To Be Amended	6
Capital Market Board Application Date	20.02.2025
Capital Market Board Application Result	APPROVAL
Capital Market Board Approval Date	27.02.2025

Additional Explanations

The Capital Markets Board's approval for the amendment to the Company's Articles of Association on the extension of the validity period of the authorized capital until the end of 2029 and the increase of its upper limit to TRY 2,000,000,000 has been received.

T he amendment will be submitted to the approval of shareholders at the first upcoming General Assembly once the approval of the Ministry of Trade is obtained.

This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure, the Turkish version shall prevail.

Supplementary Documents

Appendix: 1	TADİL TASARISI.pdf
Appendix: 2	AMENDMENT TEXT.pdf